ARCHIVES

It is The First FDA Withdrawl Of An Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 37 No. Nov 18 special report | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Expanding Tools To Improve Coordination Of Cancer Treatment

November 30, 2007

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

Pittsburgh Cancer Institute Wins SPORE Grant For Lung Cancer, For Three Major Projects.

July 20, 2001

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

November 18, 1977

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012